Edition:
United States

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

42.29USD
30 Sep 2016
Change (% chg)

$0.85 (+2.05%)
Prev Close
$41.44
Open
$41.76
Day's High
$42.47
Day's Low
$41.70
Volume
2,422,134
Avg. Vol
2,599,771
52-wk High
$46.38
52-wk Low
$36.00

Select another date:

Thu, Sep 29 2016

BRIEF-Terumo Corp looks to purchase portion of Abbott Laboratories' medical device business - Nikkei

* Terumo Corp is looking to purchase a portion of Abbott Laboratories' medical device business - Nikkei

BRIEF-Abbott receives FDA approval for the FreeStyle Libre Pro System

* Abbott receives FDA approval for the FreeStyle Libre Pro System, a revolutionary diabetes sensing technology for healthcare professionals to use with their patients Source text for Eikon: Further company coverage:

BRIEF-Abbott says malnutrition adds $15.5 bln annually to direct U.S. medical costs

* Research Shows Malnutrition Associated With Disease Increases Medical Spending By More Than $1 Billion Yearly In California, New York, Texas,Florida

BRIEF-Moody's says expectations for Abbott's ratings unchanged

* Moody's says expectations for Abbott's ratings unchanged following news of medical optics sale Source text for Eikon: Further company coverage:

Abbott to sell its eye care business to J&J for about $4.33 billion

Abbott Laboratories said it would sell its eye care business to Johnson & Johnson for about $4.33 billion in cash to focus on cardiovascular devices and diagnostics business.

UPDATE 3-Abbott to sell its eye care business to J&J for about $4.33 bln

Sept 16 Abbott Laboratories said it would sell its eye care business to Johnson & Johnson for about $4.33 billion in cash to focus on cardiovascular devices and diagnostics business.

BRIEF-Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 bln

* Net impact of this transaction is not expected to impact Abbott's overall targeted ongoing earnings per share in 2017.

Abbott in talks to sell its eye-surgery business to J&J - WSJ

Sept 16 Abbott Laboratories is in talks to sell its eye-surgery business to Johnson & Johnson, the Wall Street Journal reported, citing sources familiar with the matter.

Abbott, Alere agree to mediate merger dispute

Medical device maker Abbott Laboratories and Alere Inc agreed on Thursday to work with a mediator to settle their dispute over Abbott's role in obtaining U.S. antitrust clearance for its $5.8 billion takeover of the diagnostics company, but Alere voiced concern about the speed of the process.

Abbott, Alere agree to mediate merger dispute

Medical device maker Abbott Laboratories and Alere Inc agreed on Thursday to work with a mediator to settle their dispute over Abbott's role in obtaining U.S. antitrust clearance for its $5.8 billion takeover of the diagnostics company, but Alere voiced concern about the speed of the process.

Select another date: